# Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

> clinical trial · VERIFIED · 2026-07-14

Status: ACTIVE_NOT_RECRUITING · Sponsor: Dana-Farber Cancer Institute · Condition: Recurrent Head and Neck Carcinoma

- Company: Dana-Farber Cancer Institute
- Sector: Recurrent Head and Neck Carcinoma
- Primary source: https://clinicaltrials.gov/study/NCT02474368

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.